Bioactive Compounds of the Wonder Medicinal Mushroom “Ganoderma lucidum

Reference work entry
Part of the Reference Series in Phytochemistry book series (RSP)


Ganoderma lucidum is a highly praised medicinal mushroom having high demand worldwide. Intense research activities are being carried out on the medicinal applications of this mushroom that include anticancer, antiallergic, antioxidant potential, etc. This wonder mushroom contains many bioactive compounds such as polysaccharides, triterpenes, polyphenols, proteins, amino acids, and organic germanium. Ancient Chinese use this mushroom in their medicinal preparations and declared good health and longevity. Health benefits of this mushroom are highly praised in ancient manuscripts. Many pharmaceutical and beauty products made from this mushroom are available in the markets and demands high price. Cultivation and production of this mushroom are limited to certain countries, which leads to an increase in its market value. This chapter describes the details of this special mushroom, including its taxonomy, morphology, ecological and economic status, cultivation, bioactive molecules, and its medicinal applications.


Ganoderma lucidum Bioactive compounds Cultivation Therapeutic applications Polysaccharides Triterpenes 



Carbon nitrogen ratio


Extracellular polysaccharides

G. lucidum

Ganoderma lucidum


Ganoderic acid


Ganoderma triterpenes


Host Defense Potentiators


Intracellular polysaccharides


Liquid state cultivation


Liquid state fermentation




Protein-bound polysaccharide


Ribosome inactivating proteins


Reactive oxygen species


Superoxide dismutase


Solid state cultivation


Solid state fermentation


  1. 1.
    Wachtel-Galor S, Buswell JA, Tomlinson B, Benzie IFF (2004a) Lingzhi polyphorous fungus. In: Herbal and traditional medicine: molecular aspects of health. Marcel Dekker, New York, pp 179–228Google Scholar
  2. 2.
    Wasser SP (2005) Reishi or Lingzhi (G. lucidum). In: Coates P, Blackman MR, Cragg G, Levine M, Moss J, White J (eds) Encyclopaedia of dietary supplements. Marcel Dekker, New York, pp 603–622Google Scholar
  3. 3.
    Hou RH, Liao ST (2009) Research development of the artificial cultivation of G. lucidum in China. Guangdong Agric Sci 11:29–32. (In Chinese)Google Scholar
  4. 4.
    Hirose K, Niimura K, Ohara M, Oguchi Y, Matsunaga K, Kadochi J, Sugita N, Furushu T, Yoshikumi C (1988) Antiviral agent. J. P. Patent No.63316734Google Scholar
  5. 5.
    Boh B, Berovic M, Zhang J, Zhi-Bin L (2007) G. lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev 13:265–301PubMedCrossRefGoogle Scholar
  6. 6.
    Borchers AT, Stern JS, Hackman RM, Keen CL, Gershwin ME (1999) Mushrooms, tumours, and immunity. Proc Soc Exp Biol Med 221(4):281–293PubMedCrossRefGoogle Scholar
  7. 7.
    Mau JL, Lin HC, Ma JT, Song SF (2001a) Non-volatile taste components of several specialty mushrooms. Food Chem 73:461–466CrossRefGoogle Scholar
  8. 8.
    Joo SS, Ryu IW, Park JK, Yoo YM, Lee DH, Hwang KW, Choi HT, Lim CJ, Lee DI, Kim K (2008) Molecular cloning and expression of a laccase from G. lucidum, and its antioxidative properties. Mol Cell 25(1):112–118Google Scholar
  9. 9.
    Leung SWS, Yeung KY, Ricky YLS, Man YK (2002) Lingzhi (Ganoderma) research the past, present and future perspectives. In: Lin ZB (ed) Ganoderma: genetics, chemistry, pharmacology and therapeutics. Beijing medical University Press, Beijing, pp 1–9Google Scholar
  10. 10.
    Kim HW, Kim B (2002) Recent advances on the biologically active triterpenoids of G. lucidum. In: Zhi-Bin Lin (ed) Ganoderma: genetics, chemistry, pharmacology and therapeutics. Proceedings of international symposium on Ganoderma research, Shanghai, 21–23 Oct, Beijing, Medical University Press, pp 10–19Google Scholar
  11. 11.
    Chang ST, Buswell J (1999) G. lucidum (Curt.: Fr.) P. Karst. (Amphyllophoromycetidae) – a mushrooming medicinal mushroom. Int J Med Mush 1(2):139–146CrossRefGoogle Scholar
  12. 12.
    Lin SC (2000) Medicinal fungi of China-production and products development. Chinese Agricultural Press, BeijingGoogle Scholar
  13. 13.
    Chang ST, Buswell JA (2008) Safety quality control and regulational aspects relating to mushroom nutriceuticals. In: Proceedings of 6th international conference on mushroom biology and mushroom products, GAMU Gmbh, Krefeld, pp 188–95Google Scholar
  14. 14.
    Wachtel-Galor S, Yuen J, Buswell JA, Benzie IFF (2011) Chapter 9: G. lucidum (Lingzhi or Reishi) a medicinal mushroom. In: Herbal medicine: biomolecular and clinical aspects, 2nd edn. CRC Press, Boca RatonCrossRefGoogle Scholar
  15. 15.
    Wang JL, Li YB, Liu RM (2010) A new ganoderic acid from G. lucidum mycelia. J Asian Nat Prod Res 12(8):727–730PubMedCrossRefGoogle Scholar
  16. 16.
    Hanaoka R, Ueno Y, Tanaka S (2011) The water-soluble extract from cultured medium of G. lucidum (Reishi) mycelia (Designated as MAK) ameliorates murine colitis induced by trinitrobenzene sulphonic acid. Scand J Immunol 74(5):454–462PubMedCrossRefGoogle Scholar
  17. 17.
    Yang XJ, Liu J, Ye LB, Yang F, Ye L, Gao JR, Wu ZH (2006) In vitro and in vivo protective effects of proteoglycan isolated from mycelia of G. lucidum on carbon tetrachloride induced liver injury. World J Gastroenterol 12(9):1379–1385PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Arora D (1986) Mushrooms demystified, 2nd edn. Ten Speed Press, Berkeley, pp 169–164. ISBN 0-89815. Available at Scholar
  19. 19.
    Jungjing MA, Zhenjyi FU, Peiyan MA, Yanli SU, Qingjie Z (2007) Breaking and characteristics of G. lucidum spores by high speed centrifugal shearing pulveriser. J Wuhan Univ Technol Mat Sci Edit 22:617–621CrossRefGoogle Scholar
  20. 20.
    Chen AW (1999) Cultivation of the medicinal mushroom G. lucidum (Curtis: Fr.) P. Karst (Reishi) in North America. Int J Med Mush 1(3):263–282CrossRefGoogle Scholar
  21. 21.
    Jayasinghe C, Imtiaj A, Hur H, Lee GW, Lee TS, Lee UY (2008) Favourable culture conditions for mycelial growth of Korean wild strains in G. lucidum. Mycobiology 36(1):28–33PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Magday JC Jr, Bungihan ME, Dulay RMR (2014) Optimization of mycelial growth and cultivation of fruiting body of Philippine wild strain of G. lucidum. Curr Res Environ Appl Mycol 4(2):162–172CrossRefGoogle Scholar
  23. 23.
    Han JR, An CH, Yuan JM (2005) Solid-state fermentation of cornmeal with the basidiomycete G. lucidum for degrading starch and upgrading nutritional value. J Appl Microbiol 99(4):910–915PubMedCrossRefGoogle Scholar
  24. 24.
    Erkel EI (2009) The effect of different substrate mediums on yield of G. lucidum (Fr.) Karst. J Food Agric Environ 7:841–844Google Scholar
  25. 25.
    Royse DJ (1996) Specialty mushrooms. In: Janick J (ed) Progress in new crops. ASHS Press, Arlington, pp 464–475Google Scholar
  26. 26.
    Chen AW (2003) A fresh look at an ancient mushroom G. lucidum (Reishi). MushWorld – Cultivation, 18 Mar 2003. Available at
  27. 27.
    Gonzalez-Matute R, Figlas D, Devalis R, Delmastro S, Curvetto N (2002) Sunflower seed hulls as a main nutrient source for cultivating G. lucidum. Micol Apl Int 14:19–24Google Scholar
  28. 28.
    Yang FC, Hsieh C, Chen HM (2003a) Use of stillage grain from a rice-spirit distillery in the solid state fermentation of G. lucidum. Process Biochem 39:21–26CrossRefGoogle Scholar
  29. 29.
    Hsieh C, Yang F (2004) Reusing soy residue for the solid-state fermentation of G. lucidum. Bioresour Technol 91(1):105–109PubMedCrossRefGoogle Scholar
  30. 30.
    Chen AW (2004) Growing Ganoderma mushrooms. Chapter 11. Mushrooms for the tropics. Part III. Mushroom worldwide. In: Mushroom grower’s handbook 1, Oyster Mushroom Cultivation. pp 224–234. Available at
  31. 31.
    Kim HK (2001) Comparison of characteristics of G. lucidum according to geographical origins: consideration of growth characteristics. World Mushroom. Available at
  32. 32.
    Zhou XW, Siu K, Zhang YM (2012) Applied modern biotechnology for cultivation of Ganoderma and development of their products. Appl Microbiol Biotechnol 93:941–963PubMedCrossRefGoogle Scholar
  33. 33.
    Xia ZN, Jiang JA, He CZ, Liu DY (2003) Preliminary researchers on high yield cultivation techniques of Ganoderma. Hunan Agric Sci Technol 6:56–58Google Scholar
  34. 34.
    Yan MH (2000) Cultivation of G. lucidum using oak leaf and waste tea. Edible Fungi 2:22–23Google Scholar
  35. 35.
    Han XH, Wang HZ, He B (2003) A preliminary study on nutritional conditions for the strain mycelium growth of several cultivars of Ganoderma. J Hainan Univ 16:88–92Google Scholar
  36. 36.
    Wu BF, Liu LL, Fang ZH, Liu XY (2008) Effect of nutrition factors on mycelium growth of 51427 in G. lucidum. Anhui Agric Sci Bull 14:57–58Google Scholar
  37. 37.
    Maldonado MC, Saad AMS (1998) Production of pectinesterase and polygalacturonase by Aspergillus niger in submerged and solid state systems. J Ind Microbiol Biotechnol 20:34–38PubMedCrossRefGoogle Scholar
  38. 38.
    Mahapatra S, Banerjee D (2009) Extracellular tannase production by endophytic Hyalopus sp. J Gen Appl Microbiol 55:255–259PubMedCrossRefGoogle Scholar
  39. 39.
    Sanodiya BS, Takur GS, Baghel RK, Prasad GB, Bisen PS (2009) G. lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol 10(8):717–742PubMedCrossRefGoogle Scholar
  40. 40.
    Pandey A, Soccol CR, Mitchell D (2000) New developments in solid state fermentation: I- bioprocesses and products. Process Biochem 35:1153–1169CrossRefGoogle Scholar
  41. 41.
    Habijanic J, Berovic M (2000) The relevance of solid-state substrate moisturing on G. lucidum biomass cultivation. Food Technol Biotechnol 38(3):225–228Google Scholar
  42. 42.
    Zhang W, Tang YJA (2008) Novel three-stage light irradiation strategy in the submerged fermentation of medicinal mushroom G. lucidum for the efficient production of ganoderic acid and Ganoderma polysaccharides. Biotechnol Prog 24:1249–1261PubMedCrossRefGoogle Scholar
  43. 43.
    Zhuang Y, Hong J (2006) Two-way pattern solid fermentation engineering in medicinal mushrooms and further development of Chinese medicine residue. Zhong Yao Cai 31:1918–1919Google Scholar
  44. 44.
    Zhuang Y, Pan Y, Xie XM, Zhang LY (2007) The origin, development and its advantage and potential of the bi-directional solid fermentation for medicinal fungi. Edible Fungi China 26:3–6Google Scholar
  45. 45.
    Chen HZ, Chen J (2004) A preliminary report on solid-state fermentation of G. lucidum with Radix astragali containing medium. Chin J Integr Med 2:216–218CrossRefGoogle Scholar
  46. 46.
    Gu SR, Qin JZ, Chen H (2005) New solid fermentation of 14 Ganoderma strains and the study on polysaccharose content of the fermentation product. Lishizhen Med Mater Med Res 16:313–314Google Scholar
  47. 47.
    Gao Y, Gao H, Chan E, Tang W, Xu A, Yang H, Huang M, Lan J, Li X, Duan W, Xu C, Zhou S (2005) Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from G. lucidum in mice. Immunol Investig 34:171–198CrossRefGoogle Scholar
  48. 48.
    You JJ (2009) The present status and future aspect of medicinal fungi in China. Edible Fungi Chin 28:3–5Google Scholar
  49. 49.
    Mckenna DJ, Jones K, Hughes K (2002) Reishi, botanical medicines. The desk reference for major herbal supplements, 2nd edn. The Haworth Herbal Press, New York/London/Oxford, pp 825–855Google Scholar
  50. 50.
    Paterson RRM (2006) Ganoderma – a therapeutic fungal biofactory. Phytochemistry 67(18):1985–2001PubMedCrossRefGoogle Scholar
  51. 51.
    Zheng WF (2011) Drug discovery from fungal metabolites: a review of the papers in this monographical issue of mycosystema concerned with the natural resources, problems and strategies. Mycosystema 30:151–157Google Scholar
  52. 52.
    Bao XF, Dong Q, Fang JN (2000) Structure and conformation behaviour of a glucan from spores of G. lucidum (Fr.) Karst. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 32(6):557–561Google Scholar
  53. 53.
    Bao XF, Liu CP, Fang JN, Li XY (2001) Structural and immunological studies of a major polysaccharide from spores of G. lucidum (Fr.) Karst. Carbohydr Res 332:67–74PubMedCrossRefGoogle Scholar
  54. 54.
    Bao XF, Wang XS, Dong Q (2002) Structural features of immunologically active polysaccharides from G. lucidum. Phytochemistry 59(2):175–181PubMedCrossRefGoogle Scholar
  55. 55.
    Ho YW, Yeung JS, Chiu PK, Tang WM, Lin ZB, Man RY, Lau CS (2007) G. lucidum polysaccharide peptide reduced the production of proinflammatory cytokines in activated rheumatoid synovial fibroblast. Mol Cell Biochem 301(1–2):173–179PubMedCrossRefGoogle Scholar
  56. 56.
    Li Z, Liu J, Zhao Y (2005) Possible mechanism underlying the antiherpetic activity of a proteoglycan isolated from the mycelia of G. lucidum in vitro. J Biochem Mol Biol 38(1):34–40PubMedGoogle Scholar
  57. 57.
    Ji Z, Tang Q, Zhang J, Yang Y, Jia W, Pan Y (2007) Immunomodulation of RAW264.7 macrophages by GLIS, a proteopolysaccharide from G. lucidum. J Ethnopharmacol 112(3):445–450PubMedCrossRefGoogle Scholar
  58. 58.
    Wu Y, Wang D (2009) A new class of natural glycopeptides with sugar moiety-dependent antioxidant activities derived from G. lucidum fruiting bodies. J Proteome Res 8:436–442PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Chien CM, Cheng JL, Chang WT (2004) Polysaccharides of G. lucidum alter cell immunophenotypic expression and enhance CD56+ NK-cell cytotoxicity in cord blood. Bioorg Med Chem 12:5603–5609PubMedCrossRefGoogle Scholar
  60. 60.
    Dong SF, Chen JM, Zhang W, Sun SH, Wang J, Gu JX, Boraschi D, Qu D (2007) Specific immune response to HBsAg is enhanced by β-glucan oligosaccharide containing α-(1→3)-linked bond and biased towards M2/Th2. Int Immunopharmacol 7:725–733PubMedCrossRefGoogle Scholar
  61. 61.
    Fatmawati S, Kondo R (2011) Structure-activity relationships of ganoderma acids from G. lucidum as aldose reductase inhibitors. Bioorg Med Chem Lett 21(24):7295–7297PubMedCrossRefGoogle Scholar
  62. 62.
    Weng CJ, Chau CF, Chen KD, Chen DH, Yen GC (2007) The anti-invasive effect of lucidenic acids isolated from a new G. lucidum strain. Mol Nutr Food Res 51:1472–1477PubMedCrossRefGoogle Scholar
  63. 63.
    Gao JI, Leung KS, Wang YT, Lai CM, Li SP, Hu LF, Lu GH, Jiang ZH, Yu ZL (2007) Qualitative and quantitative analyses of nucleosides and nucleobases in Ganoderma spp. by HPLC-DAD-MS. J Pharm Biomed Anal 44(3):807–811PubMedCrossRefGoogle Scholar
  64. 64.
    Van Der Hem LG, Van Der Vliet JA, Bocken CF, Kino K, Hoitsma AJ, Tax WJ (1995) Lingzhi-8: studies of a new immunomodulating agent. Transplantation 60:438–443PubMedCrossRefGoogle Scholar
  65. 65.
    Wang H, Ng TB (2006) Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom G. lucidum. Peptides 27(1):27–30PubMedCrossRefGoogle Scholar
  66. 66.
    Kim SD, Nho HJ (2004) Isolation and characterization of alpha-glucosidase inhibitor from the fungus G. lucidum. J Microbiol 42(3):223–227PubMedGoogle Scholar
  67. 67.
    Liu JJ, Huang WH, Lv ML, Si JP, Guo BL, Li SJ (2011) Determination of Ergosterol in G. lucidum from different varieties and cultured tree species by HPLC. Zhong Yao Cai 34:187–190PubMedGoogle Scholar
  68. 68.
    Gao P, Hirano T, Chen Z, Yasuhara T, Nakata Y, Sugimoto A (2012) Isolation and identification of C-19 fatty acids with anti-tumor activity from the spores of G. lucidum (Reishi mushroom). Fitoterapia 83:490–499PubMedCrossRefGoogle Scholar
  69. 69.
    Fukuzawa M, Hide I, Chen Z, Hirai Y, Sugimoto A, Yasuhara T, Nakata Y (2008) Possible involvement of long chain fatty acids in the spores of G. lucidum (Reishi Houshi) to its anti-tumor activity. Biol Pharm Bull 31:1933–1937PubMedCrossRefGoogle Scholar
  70. 70.
    Matute RG, Serra A, Figlas D, Curvetto N (2011) Copper and zinc bioaccumulation and bioavailability of G. lucidum. J Med Food 14(10):1273–1279PubMedCrossRefGoogle Scholar
  71. 71.
    Falandysz J (2008) Selenium in edible mushrooms. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 26(3):256–299PubMedCrossRefGoogle Scholar
  72. 72.
    Huie CW, Di X (2004) Chromatographic and electrophoretic methods for Lingzhi pharmacologically active components. J Chromatogr B 812:241–257CrossRefGoogle Scholar
  73. 73.
    Chang YW, Lu T (2004) Molecular characterization of polysaccharides in hot water extracts of G. lucidum fruiting bodies. J Food Drug Anal 12:59–67Google Scholar
  74. 74.
    Gao Y, Zhou S, Chen G, Dai X, Ye J, Gao H (2002) A phase I/II study of a G. lucidum (Curt.: Fr.) P. Karst. (Lingzhi, Reishi mushroom) extract in patients with chronic hepatitis B. Int J Med Mush 4:321–327Google Scholar
  75. 75.
    Cheong J, Jung W, Park W (1999) Characterization of an alkali-extracted peptidoglycan from Korean G. lucidum. Arch Pharm Res 22:515–519PubMedCrossRefGoogle Scholar
  76. 76.
    Fang QH, Zhong JJ (2002a) Effect of initial pH on production of ganoderic acid and polysaccharide by submerged fermentation of G. lucidum. Process Biochem 37:769–774CrossRefGoogle Scholar
  77. 77.
    Wang YY, Chen ST, Lin CC, Wong CH, Lin CH (2002) Studies on the immunomodulation and antitumor activities of G. lucidum (Reishi) polysaccharides: functional and proteomic analysis of fucose-containing glycoprotein fraction responsible for the activities. Bioorg Med Chem 10:1057–1062PubMedCrossRefGoogle Scholar
  78. 78.
    Lin SQ, Wang SZ, Lin ZB, Lin YX (2002) Purification and identification of glycopeptides from G. lucidum fruit bodies cultivated with grass and wood log. In: Zhi-Bin Lin (ed) Ganoderma: genetics, chemistry, pharmacology and therapeutics. Proceedings of international symposium on Ganoderma research, Shanghai, 21–23 Oct, Beijing, Medical University Press, pp 109–114Google Scholar
  79. 79.
    Zhang QH, Lin ZB (1999) Effect of G. lucidum polysaccharides B on TNF-a and INF-g production and their mRNA expression. Beijing Yi Ke Da Xue Xue Bao 31:179–183Google Scholar
  80. 80.
    Ooi LSM, Ooi VEC, Fung MC (2002) Induction of gene expression of immunomodulatory cytokines in the mouse by a polysaccharide from G. lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae). Int J Med Mush 4:27–35CrossRefGoogle Scholar
  81. 81.
    Kidd PH (2000) The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 5:4–27PubMedGoogle Scholar
  82. 82.
    Kang YK, Yoon SI, Lee SY, Kim DD, Lee SJ, Park WH, Hudson SM (2010) Chitosan-coated poly (vinyl alcohol) nanofibers for wound dressings. J Biomed Mater Res Part B Appl Biomater 92(2):568–576Google Scholar
  83. 83.
    Wasser SP, Weis AL (1997) Reishi mushroom [G. lucidum (Curt.: Fr.) P. Karst.] In: Nevo E (ed) Medicinal mushrooms. Peledfus, Haifa, p 39Google Scholar
  84. 84.
    Hobbs CH (1995) Medicinal mushrooms: an exploration of tradition, healing and culture, 2nd edn. Botanica Press, Santa Cruz, p 252Google Scholar
  85. 85.
    Min BS, Gao JJ, Hattori M, Lee HK, Kim YH (2001) Anticomplement activity of terpenoids from the spores of G. lucidum. Planta Med 67(9):811–814PubMedCrossRefGoogle Scholar
  86. 86.
    Luo J, Lin ZB (2002) Advances of pharmacological effects of triterpenes from G. lucidum. Acta Pharm Sin B 37:574–578Google Scholar
  87. 87.
    Frankel EN (1997) Nutritional benefits of flavonoids. In: Ohigashi H, Osawa T, Terao J, Watanabe S, Yoshikawa T (eds) Food factors for cancer prevention. Springer, Tokyo, pp 6l3–616Google Scholar
  88. 88.
    Decker EA (1997) Phenolics: prooxidants or antioxidants? Nutr Rev 55:396–407PubMedCrossRefGoogle Scholar
  89. 89.
    Mau JL, Lin HC, Song SF (2002) Antioxidant properties of several specialty mushrooms. Food Res Int 35(6):519–526CrossRefGoogle Scholar
  90. 90.
    Kumari K, Prakash V, Rana S, Sagar A (2016) In vitro antioxidant activity of methanolic extract of G. lucidum (Curt.) P. Karst. IJASR 1(5):51–54Google Scholar
  91. 91.
    Heleno SA, Barros L, Martins A, Ferreira ICFR (2012) Fruiting body spores and in vitro produced mycelium of G. lucidum from Northeast Portugal: a comparative study of the antioxidant potential of phenolic and polysaccharidic extracts. Food Res Int 46:135–140CrossRefGoogle Scholar
  92. 92.
    Hajjaj H, Mace M, Roberts M, Niederberger P, Fay LB (2005) Effect of 26-oxygenosterols from G. lucidum and their activity as cholesterol synthesis inhibitors. Appl Environ Microbiol 71:3653–3658PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Zhang CR, Yang SP, Yue JM (2008) Sterols and triterpenoids from the spores of G. lucidum. Nat Prod Res 22(13):1137–1142PubMedCrossRefGoogle Scholar
  94. 94.
    Lv GP, Zhao J, Duan JA, Tang YP, Li SP (2012) Comparison of sterols and fatty acids in two species of Ganoderma. Chem Cent J 6(1):10PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Xu XF, Yan HD, Chen J, Zhang XW (2011) Bioactive proteins from mushrooms. Biotechnol Adv 29:667–674PubMedCrossRefGoogle Scholar
  96. 96.
    Kawagishi H, Yamawaki M, Ido M, Shimada A, Kinoshita T, Murata T, Usui T, Kimura A, Chiba S (1997) A lectin from mycelia of the fungus G. lucidum. J Phytochem 44:7–10CrossRefGoogle Scholar
  97. 97.
    Li YG, Ji DF, Zhong S, Zhu JX, Chen S, Hu GY (2011a) Anti-tumor effects of proteoglycan from Phellinus linteus by immunomodulating and inhibiting Reg IV/EGFR/Akt signalling pathway in colorectal carcinoma. Int J Biol Macromol 48:511–517PubMedCrossRefGoogle Scholar
  98. 98.
    Kino K, Yamashita A, Yamaoka K, Watanabe J, Tanaka S, Ko K, Shimizu K, Tsunoo H (1989) Isolated and characterization of a new immunomodulatory protein Lingzhi-8 (LZ-8), from G. lucidum. J Biol Chem 264:472–478PubMedGoogle Scholar
  99. 99.
    Li QZ, Wang XF, Zhou XW (2011b) Recent status and prospects of the fungal immunomodulatory protein family. Crit Rev Biotechnol 31:365–375PubMedCrossRefGoogle Scholar
  100. 100.
    Tsai LL (2007) Immunomodulatory protein cloned from G. microsporum. US Patent US 7601808 B2Google Scholar
  101. 101.
    Huang J, Zhang LX, Hu SN, Yu LJ (2008) Optimizing expression of LZ-8 protein and primary assaying of its immunomodulatory activity. Zhejiang Univ (Agric & Life Sci) 34:7–12Google Scholar
  102. 102.
    Shimizu A, Yano T, Saito Y, Inada Y (1985) Isolation of an inhibitor of platelet aggregation from a fungus, G. lucidum. Biol Pharm Bull 33(7):3012–3015Google Scholar
  103. 103.
    Gao Y, Zhou SH, Huang M, Xu A (2003) Antibacterial and antiviral value of the genus Ganoderma P. Karst. species (Aphyllophoromycetideae): a review. Int J Med Mush 5(3):235–246CrossRefGoogle Scholar
  104. 104.
    Hardy S, Przybytkowski E, Joly E, Prentki M, Langelier Y (2003) Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J Biol Chem 278:31861–31870PubMedCrossRefGoogle Scholar
  105. 105.
    Ihayere CA, Oghenekaro AO, Osemwegie OO, Okhuoya JA (2010) Chemical nature of G. lucidum (Curtis) Karsten from woodlands of Edo state, Nigeria. C J Biol Sci 3:8–15Google Scholar
  106. 106.
    Mizuno T (1995) G. lucidum and G. tsugae: bioactive substances and medicinal effects. Food Rev Int 11(1):151–166CrossRefGoogle Scholar
  107. 107.
    Stamets P (2000) Growing gourmet and medicinal mushrooms, 3rd edn. Ten Speed Press, Berkeley, p 339Google Scholar
  108. 108.
    Chen DH, Shiou WY, Wang KC, Hwang SY, Shie YT, Tsai CM, Shie JF, Chen KD (1999) Chemotaxonomy of triterpenoid pattern of HPLC of G. lucidum and G. tsugae. J Chin Inst Chem 46:47–51CrossRefGoogle Scholar
  109. 109.
    Gao JJ, Nakamura N, Min BS, Hirakawa A, Zuo F, Hattori M (2004) Quantitative determination of bitter principles in specimens of G. lucidum using high-performance liquid chromatography and its application to the evaluation of Ganoderma products. Chem Pharm Bull 52(6):688–695CrossRefGoogle Scholar
  110. 110.
    Liu GT (1999) Recent advances in research of pharmacology and clinical applications of Ganoderma P. Karst. species (Aphyllophoromycetideae) in China. Int J Med Mush 1(1):63–68CrossRefGoogle Scholar
  111. 111.
    Chiu SW, Wang ZM, Leung TM, Moore D (2000) Nutritional value of Ganoderma extract and assessment of its genotoxicity and antigenotoxicity using comet assays of mouse lymphocytes. Food Chem Toxicol 38:173–178PubMedCrossRefGoogle Scholar
  112. 112.
    Kolesnikova OP, Tuzova MN, Kozlov VA (1997) Screening of immunoactive properties of alkanecarbonic acid derivatives and germanium-organic compounds in vivo. Immunologiya 10:36–38Google Scholar
  113. 113.
    Li P, Yi L, Liu HJ (2011) Chapter 2: Collection and identification of raw herbal materials. In: Liu JH (ed) Traditional herbal medicine research methods: identification, analysis, bioassay, and pharmaceutical and clinical studies. John Wiley & Sons, Inc., Hoboken, New Jersey, pp 27–79CrossRefGoogle Scholar
  114. 114.
    Krishnaswamy N (2010) Chemistry of natural products: the terpenes. Taylor & Francis Group, New York, pp 1–10CrossRefGoogle Scholar
  115. 115.
    Kim DO, Lee CY (2003). Extraction and isolation of polyphenolics. In: Current protocols in food analytical chemistry, I:I1:I1.2 (Online)Google Scholar
  116. 116.
    Fan L, Li J, Deng K, Ai L (2012) Effects of drying methods on the antioxidant activities of polysaccharides extracted from G. lucidum. Carbohydr Polym 87(2):1849–1854CrossRefGoogle Scholar
  117. 117.
    Liu GQ, Zhao Y, Wang XL, Zhu CY (2011) Response surface methodology for optimization of polysaccharides extraction by mild alkaline hydrolysis from fruiting body of medicinal mushroom, G. lucidum. J Med Plant Res 5(10):2064–2070Google Scholar
  118. 118.
    Chin SK, Law C, Cheng P (2011) Effect of drying on crude ganoderic acids and water soluble polysaccharides content in G. lucidum. Int J Pharm Pharm Sci 3:38–43Google Scholar
  119. 119.
    Chin SK, Law CL, Supramaniam CV, Cheng PG (2009) Thin-layer drying characteristics and quality evaluation of air-dried Ganoderma tsugae Murrill. Dry Technol 27(9):975–984CrossRefGoogle Scholar
  120. 120.
    Huang SQ, Ning ZX (2010) Extraction of polysaccharide from Ganoderma lucidum and its immune enhancement activity. Int J Biol Macromol 47(3):336–341PubMedCrossRefGoogle Scholar
  121. 121.
    Liu W, Xu J, Jing P, Yao W, Gao X, Yu L (2010) Preparation of a hydroxypropyl G. lucidum polysaccharide and its physicochemical properties. Food Chem 122(4):965–971CrossRefGoogle Scholar
  122. 122.
    Chen W, Wang WP, Zhang HS, Huang Q (2012) Optimization of ultrasonic-assisted extraction of water-soluble polysaccharides from Boletus edulis mycelia using response surface methodology. Carbohydr Polym 87(1):614–619CrossRefPubMedGoogle Scholar
  123. 123.
    Wen L, Lin L, You L, Yang B, Jiang G, Zhao M (2011) Ultrasound-assisted extraction and structural identification of polysaccharides from Isodon lophanthoides var. gerardianus (Bentham) H. Hara. Carbohydr Polym 85(3):541–547CrossRefGoogle Scholar
  124. 124.
    Zhao Q, Kennedy JF, Wang X, Yuan X, Zhao B, Peng Y et al (2011) Optimization of ultrasonic circulating extraction of polysaccharides from Asparagus officinalis using response surface methodology. Int J Biol Macromol 49(2):181–187PubMedCrossRefGoogle Scholar
  125. 125.
    Chen X, Wang W, Li S, Xue J, Fan L, Sheng Z et al (2010) Optimization of ultrasound-assisted extraction of Lingzhi polysaccharides using response surface methodology and its inhibitory effect on cervical cancer cells. Carbohydr Polym 80(3):944–948CrossRefGoogle Scholar
  126. 126.
    Hromadkova Z, Ebringerova A, Valachovič P (1999) Comparison of classical and ultrasound-assisted extraction of polysaccharides from Salvia officinalis L. Ultrason Sonochem 5(4):163–168PubMedCrossRefGoogle Scholar
  127. 127.
    Huang SQ, Li JW, Wang Z, Pan HX, Chen JX, Ning ZX (2010) Optimization of alkaline extraction of polysaccharides from G. lucidum and their effect on immune function in mice. Molecules 15(5):3694–3708PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Xu DJ, Xia Q, Wang JJ, Wang PP (2008) Molecular weight and monosaccharide composition of Astragalus polysaccharides. Molecules 13(10):2408–2415PubMedPubMedCentralCrossRefGoogle Scholar
  129. 129.
    Zhao L, Dong Y, Chen G, Hu Q (2010) Extraction, purification characterization and antitumor activity of polysaccharides from G. lucidum. Carbohydr Polym 80:783–789CrossRefGoogle Scholar
  130. 130.
    Wakte P, Sachin B, Patil A, Mohato D, Band T, Shinde D (2011) Optimization of microwave, ultra-sonic and supercritical carbon dioxide assisted extraction techniques for curcumin from Curcuma longa. Sep Purif Technol 79(1):50–55CrossRefGoogle Scholar
  131. 131.
    Claver IP, Zhang H, Li Qin Z, Huiming Z (2010) Optimization of ultrasonic extraction of polysaccharides from Chinese malted sorghum using response surface methodology. Pak J Nutr 9(4):336–342CrossRefGoogle Scholar
  132. 132.
    Kozarski M, Klaus A, Nikšić M, Vrvić MM, Todorović N, Jakovljević D, Van Griensven LJ (2012) Antioxidative activities and chemical characterization of polysaccharide extracts from the widely used mushrooms G. applanatum, G. lucidum, Lentinus edodes and Trametes versicolor. J Food Compos Anal 26(1):144–153CrossRefGoogle Scholar
  133. 133.
    Cheung YC, Siu KC, Liu YS, Wu JY (2012) Molecular properties and antioxidant activities of polysaccharide–protein complexes from selected mushrooms by ultrasound-assisted extraction. Process Biochem 47(5):892–895CrossRefGoogle Scholar
  134. 134.
    Azmi AF, Mustafa S, Hashim DM, Manap YA (2012) Prebiotic activity of polysaccharides extracted from Gigantochloa levis (Buluh beting) shoots. Molecules 17(2):1635–1651PubMedPubMedCentralCrossRefGoogle Scholar
  135. 135.
    Li YQ, Fang L, Zhang KC (2007) Structure and bioactivities of a galactose rich extracellular polysaccharide from submergedly cultured G. lucidum. Carbohydr Polym 68(2):323–328CrossRefGoogle Scholar
  136. 136.
    Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28:350–356CrossRefGoogle Scholar
  137. 137.
    Miyazaki T, Nishijima M (1982) Structural examination of an alkali-extracted, water-soluble hetero glycan of the fungus G. lucidum. Carbohydr Res 109(1):290–294CrossRefGoogle Scholar
  138. 138.
    Sone Y, Okuda R, Wada N, Kishida E, Misaki A (1985) Structure and antitumor activities of the polysaccharide isolated from fruiting body and the growing culture of mycelium of G. lucidum. Agric Biol Chem 49:2641–2653Google Scholar
  139. 139.
    Kim HW, Kim BK (1999) Biomedical triterpenoids of G. lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae). Int J Med Mush 1(2):121–138CrossRefGoogle Scholar
  140. 140.
    Min BS, Nakamura N, Miyashiro H et al (1998) Triterpenes from the spores of G lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull 46(10):1607–1612CrossRefGoogle Scholar
  141. 141.
    Fang QH, Zhong JJ (2002b) Submerged fermentation of higher fungus G. lucidum for production of valuable bioactive metabolites – ganoderic acid and polysaccharide. Biochem Eng J 10:61–65CrossRefGoogle Scholar
  142. 142.
    Ma J, Ye Q, Hua Y, Zhang D, Cooper R, Chang MN, Chang JY, Sun HH (2002) New lanostanoids from the mushroom G. lucidum. J Nat Prod 65:72–75PubMedCrossRefGoogle Scholar
  143. 143.
    Tang YJ, Zhong JJ (2002) Exopolysaccharide biosynthesis and related enzyme activities of the medicinal fungus, G. lucidum, grown on lactose in a bioreactor. Biotechnol Lett 24:1023–1026CrossRefGoogle Scholar
  144. 144.
    Kikuchi T, Kanomi S, Kadota S, Murai Y, Tsubono K, Ogita Z (1986) Constituents of the fungus G. lucidum (Fr.) Karst. I. Structures of ganoderic acids C2, E, I, and K, lucidenic acid F and related compounds. Chem Pharm Bull 34:3695–3712CrossRefGoogle Scholar
  145. 145.
    Hirotani MA, Furaya T, Shiro M (1985) A ganoderic acid derivative, a highly oxygenated lanostane-type triterpenoid from G. lucidum. Phytochemistry 24(9):2055–2061CrossRefGoogle Scholar
  146. 146.
    Sliva D (2004) Cellular and physiological effects of G. lucidum (Reishi). Mini-Rev Med Chem 4:873–879PubMedCrossRefGoogle Scholar
  147. 147.
    Yuen JW, Gohel MD (2005) Anticancer effects of G. lucidum: a review of scientific evidence. Nutr Cancer 53:11–17PubMedCrossRefGoogle Scholar
  148. 148.
    Tomasi S, Lohezic-Le DF, Sauleau P, Bezivin C, Boustie J (2004) Cytotoxic activity of methanol extracts from Basidiomycete mushrooms on murine cancer cell lines. Pharmazie 59:290–293PubMedGoogle Scholar
  149. 149.
    Chen WC, Hau DM, Wang CC, Lin IH, Lee SS (1995) Effects of G. lucidum and krestin on subset T-cell in spleen of gamma-irradiated mice. Am J Chin Med 23:289–298PubMedCrossRefGoogle Scholar
  150. 150.
    Lu ZW (1995) Psycho-neuroimmunological effects of morphine and the immunoprotection of Ganoderma polysaccharides peptide in morphine dependent mice. Chin J Phys 26:45–49Google Scholar
  151. 151.
    Benzie IFF, Wachtel-Galor S (2009) Biomarkers of long-term vegetarian diets. Adv Clin Chem 47:169–220Google Scholar
  152. 152.
    Yuen JW, Gohel MD (2008) The dual roles of Ganoderma antioxidants on urothelial cell DNA under carcinogenic attack. J Ethnopharmacol 118:324–330PubMedCrossRefGoogle Scholar
  153. 153.
    Saltarelli R, Ceccaroli P, Lotti M, Zambonelli A, Buffalini M, Casadei L, Vallorani L, Stocchi V (2009) Biochemical characterisation and antioxidant activity of mycelium of G. lucidum from Central Italy. Food Chem 116:143–151CrossRefGoogle Scholar
  154. 154.
    Wachtel-Galor S, Szeto YT, Tomlinson B, Benzie FIF (2004b) G. lucidum (Lingzhi): acute and short-term biomarker response to supplementation. Int J Food Sci Nutr 1:75–83CrossRefGoogle Scholar
  155. 155.
    Ooi VEC, Liu F (2000) Immunomodulation and anti-cancer activity of polysaccharide–protein complexes. Curr Med Chem 7:715–729PubMedCrossRefGoogle Scholar
  156. 156.
    Lee JM, Kwon H, Jeong H, Lee JW, Lee SY, Baek SJ, Surh YJ (2001) Inhibition of lipid peroxidation and oxidative DNA damage by G. lucidum. Phytother Res 15:245–249PubMedCrossRefGoogle Scholar
  157. 157.
    Shi YL, James AE, Benzie IF, Buswell JA (2002) Mushroom-derived preparations in the prevention of H2O2-induced oxidative damage to cellular DNA. Teratog Carcinog Mutagen 22:103–111PubMedCrossRefGoogle Scholar
  158. 158.
    Sheena M, Ajith A, Janardhanan K (2003) Prevention of nephrotoxicity induced by the anticancer drug cisplatin, using G. lucidum, a medicinal mushroom occurring in South India. Curr Sci 85:478–482Google Scholar
  159. 159.
    Yue QX, Xie FB, Guan SH, Ma C, Yang M, Jiang BH, Liu X, Guo DA (2008) Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenes. Cancer Sci 99:1461–1470PubMedCrossRefGoogle Scholar
  160. 160.
    Jia J, Zhang XI, Hu YS, Wu Y, Wang QZ, Li NN, Guo QC, Dong XC (2009) Evaluation of in vivo antioxidant activities of G. lucidum polysaccharides in STZ-diabetic rats. Food Chem 115:32–36CrossRefGoogle Scholar
  161. 161.
    Calder PC (2003) Immunonutrition: may have beneficial effects in surgical patients. BMJ 327(7407):117–118PubMedPubMedCentralCrossRefGoogle Scholar
  162. 162.
    Powell M (2006) G. lucidum (Reishi) in the management of histamine-mediated allergic responses. Townsend Letter pp 78–81Google Scholar
  163. 163.
    Yoon SY, Eo SK, Kim YS, Lee CK, Han SS (1994) Antimicrobial activity of G. lucidum extract alone and in combination with some antibiotics. Arch Pharm Res 17:438–442PubMedCrossRefGoogle Scholar
  164. 164.
    Mohammed A, Adelaiye AB, Abubakar MS, Abdurahman EM (2007) Effects of aqueous extract of G. lucidum on blood glucose levels of normoglycemic and alloxan induced diabetic wistar rats. J Med Plant Res 1:34–37Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Chemical and Environmental Engineering, Faculty of EngineeringUniversity of NottinghamSemenyihMalaysia
  2. 2.Centre of Excellence for Postharvest Biotechnology (CEPB), School of BiosciencesUniversity of NottinghamSemenyihMalaysia

Personalised recommendations